Brussels, 12/10/2007 (Agence Europe) - On 11 October, the European Commission cleared the planned acquisition of Organon BS of the Netherlands, a subsidiary of Akzo Nobel active worldwide in human and animal health, by the global pharmaceutical company Schering-Plough Corporation (SP) of the US, subject to conditions. The Commission found that the proposed transaction as initially notified would have given rise to competition concerns in 12 product areas and more than 30 relevant national...